Croda International (LON:CRDA) Releases Earnings Results

Key Points

• Croda International reported quarterly earnings of GBX 72.20 ($0.96) per share, with a net margin of 9.98% and return on equity of 6.96%.
• The company has a market capitalization of £3.73 billion and a current ratio of 2.72, indicating strong liquidity.
• Insiders purchased a total of 1,284 shares of company stock in the last quarter, demonstrating confidence in Croda International's growth potential.

Croda International (LON:CRDA - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX 72.20 ($0.96) earnings per share for the quarter, Digital Look Earnings reports. Croda International had a return on equity of 6.96% and a net margin of 9.98%.

Croda International Stock Up 0.6%

LON:CRDA traded up GBX 15 ($0.20) during mid-day trading on Friday, hitting GBX 2,627 ($34.87). 536,042 shares of the company's stock traded hands, compared to its average volume of 1,088,552. The company has a fifty day moving average of GBX 2,967.84 and a 200 day moving average of GBX 3,025.97. Croda International has a twelve month low of GBX 2,527 ($33.54) and a twelve month high of GBX 4,335 ($57.54). The company has a market capitalization of £3.67 billion, a P/E ratio of 22.57, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72.

Insiders Place Their Bets

In other news, insider Stephen Oxley acquired 3,762 shares of the business's stock in a transaction dated Tuesday, July 29th. The shares were acquired at an average cost of GBX 2,671 ($35.45) per share, with a total value of £100,483.02 ($133,372.74). Also, insider Ian Bull acquired 1,000 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was purchased at an average cost of GBX 3,011 ($39.97) per share, for a total transaction of £30,110 ($39,965.49). Over the last quarter, insiders purchased 6,346 shares of company stock valued at $17,310,982. 0.93% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CRDA shares. Deutsche Bank Aktiengesellschaft decreased their price objective on Croda International from GBX 3,400 ($45.13) to GBX 3,000 ($39.82) and set a "hold" rating for the company in a research note on Tuesday. JPMorgan Chase & Co. upgraded Croda International to an "overweight" rating in a research note on Wednesday. Berenberg Bank reduced their target price on Croda International from GBX 3,800 ($50.44) to GBX 3,100 ($41.15) and set a "buy" rating on the stock in a research report on Tuesday. Finally, Citigroup reduced their target price on Croda International from GBX 3,550 ($47.12) to GBX 3,300 ($43.80) and set a "neutral" rating on the stock in a research report on Tuesday, April 29th.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.